PUMA BIOTECHNOLOGY INC Chart calendar Puma Biotechnology Inc
1.gPaDv4DTFFuNBS2q46zuty_rk_tsdspL5xIY-6zac6k.zMDH-NKrJD3YKEnGoea88Uis0JJZF656lWVCtPzsO_uwpdfd8ZsjNLUoYA~efe329cedb4d6eadea9deee4839d8ab6
Upcoming events on Puma Biotechnology Inc
Past events on Puma Biotechnology Inc
| 2024-03-06 09:10 am | TD Cowen Health Care Conference |
| 2024-02-29 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-18 02:00 pm | B. Riley Securities Oncology Conference |
| 2023-11-02 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-02 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-14 12:30 pm | AACR-NCI-EORTC International Conference |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-13 04:00 pm | Annual General Meeting |
| 2023-06-12 | Annual General Meeting |
| 2023-06-01 | American Society of Clinical Oncology Conference |
| 2023-05-04 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-04 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-07 10:30 am | Cowen Health Care Conference |
| 2023-03-02 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-02 04:05 pm | Q4 2022 Earnings Release |
| 2023-01-19 02:00 pm | B. Riley Securities Oncology Conference |
| 2022-11-03 04:30 pm | Q3 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 272 269 1.11% | 225 225 -0.1% | 253 245 3.34% | 228 219 3.92% | 236 237 -0.61% | 231 |
|
EBITDA Million USD | Released Forecast Spread | -31,0 -47,9 35.27% | -20,4 -17,9 -13.93% | 11,9 18,6 -36.15% | 32,6 35,8 -8.84% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -39,1 -47,7 18.02% | -30,4 -26,3 -15.66% | 1,30 2,57 -49.39% | 23,7 24,5 -3.09% | 32,6 36,0 -9.44% | 24,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -75,6 -77,2 2.13% | -59,8 -50,6 -18.14% | -28,8 -37,4 23.01% | 0,50 8,30 -93.98% | 22,7 23,8 -4.62% | 13,4 |
|
Net income Million USD | Released Forecast Spread | -75,6 -77,7 2.68% | -60,0 -54,2 -10.68% | -29,1 -38,9 25.17% | 0,00 8,30 - | 21,6 24,3 -10.93% | 13,5 |
|
EPS USD | Released Forecast Spread | -1,95 -2,08 6.21% | -1,52 -1,41 -8.19% | -0,72 -0,87 16.91% | 0,00 0,17 - | 0,45 0,49 -9.03% | 0,26 |
| Announcement Date | 20/02/20 | 25/02/21 | 03/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 55,4 47,2 17.46% | 45,7 45,1 1.41% | 59,5 52,6 13.07% | 57,1 50,5 13.15% | 65,7 57,1 15.14% | 52,8 49,6 6.38% | 54,6 51,7 5.54% | 56,1 58,0 -3.19% | 72,2 73,6 -1.84% | 49,1 | 58,8 | 58,5 | 64,3 |
|
EBITDA Million USD | Released Forecast Spread | 4,62 3,68 25.54% | 7,77 15,7 -50.58% | |||||||||||
|
EBIT Million USD | Released Forecast Spread | 6,80 -3,80 278.95% | -0,70 -3,37 79.21% | 12,1 3,94 206.87% | 2,39 -0,77 409.44% | 10,0 7,62 31.21% | 4,40 1,63 169.26% | 4,90 4,28 14.46% | 8,60 6,70 28.36% | 14,8 18,1 -18.23% | -7,70 | 8,90 | 9,00 | 14,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4,40 -4,05 208.64% | -3,40 -8,50 60% | 9,50 -0,90 1155.56% | -0,29 -5,50 94.67% | -5,30 2,60 -303.85% | 1,60 -4,30 137.21% | 2,30 0,70 228.57% | 6,00 4,30 39.53% | 12,8 13,9 -7.91% | -11,4 | 5,80 | 8,30 | 10,7 |
|
Net income Million USD | Released Forecast Spread | 4,20 -4,05 203.7% | -3,40 -7,43 54.26% | 9,40 0,60 1466.67% | -0,36 -5,35 93.27% | -5,60 2,75 -303.64% | 1,40 -4,15 133.73% | 2,10 0,20 950% | 5,80 3,80 52.63% | 12,3 15,0 -17.73% | -10,2 | 6,15 | 6,20 | 11,3 |
|
EPS USD | Released Forecast Spread | 0,10 -0,09 212.93% | -0,08 -0,17 51.53% | 0,21 0,01 1954.79% | -0,01 -0,07 86.31% | -0,12 0,05 -366.67% | 0,03 -0,08 140% | 0,05 0,01 566.67% | 0,12 0,08 56.51% | 0,26 0,30 -13.24% | -0,22 | 0,03 | 0,14 | 0,27 |
| Announcement Date | 03/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 02/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 29/02/24 | - | - | - | - |
| Today 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
